Automated description from the Alliance of Genome Resources (Release 3.0)
Predicted to have identical protein binding activity and protein N-terminus binding activity. Predicted to be involved in several processes, including negative regulation of cell cycle; positive regulation of protein ubiquitination; and protein stabilization. Predicted to localize to microtubule cytoskeleton and nucleus. Human ortholog(s) of this gene implicated in breast cancer; reproductive organ cancer (multiple); transitional cell carcinoma; and urinary system cancer (multiple). Is expressed in liver and metanephros. Orthologous to human RASSF1 (Ras association domain family member 1).